Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Reddit Shares Slide Nearly 6 as Meta Launches Competing Forum App Indias FDI Landscape Shifts Net Inflows Rise on Stronger Gross Capital Outward Investments Surge UKGulf Trade Deal Poised as Monumental Achievement Says Bahrain Minister in CNBC Interview UnitedHealth Group UNH Picked as Top Dividend Stock by Hedge Funds Mizuho Lifts Price Target to 440 RBI Dividend Payout and Geopolitical Tensions Key Factors Shaping Indian Stock Market This Week KAI Q1 2026 Earnings EPS Surges Past Estimates Stock Reacts Positively KOD Q1 2026 Earnings Narrower Loss on Lower Spending as Pipeline Progress Continues RCEL Q1 2026 Earnings EPS Misses Estimates Stock Gains Amid Operational Progress PERF Q1 2026 Earnings EPS Beat Boosts Investor Sentiment FMC Q1 2026 Earnings EPS Surpasses Estimates Despite Loss Shares Rise TechnipFMC FTI Consolidates Near 7141 Holding Support Above Key Level Indigo Acquisition Corp Unit INACU Holds Steady at 1028 as SPAC Units Trade in Tight Range John Hancock Preferred Income Fund HPI Holds Steady Near 1606 as Key Support and Resistance Levels Define Potential Path Medifast MED Shares Edge Lower Amid Consolidation Near Support Levels Jim Cramer Expresses Admiration for Target TGT Amid Retail Landscape Micron Shares Surge Toward Best Month Since 1987 Analysts Highlight Value Opportunity Huawei Unveils New Chip Design Approach Intensifying Rivalry with Nvidia and Apple Ahead of Fall Launch Burberry Shares Surge on Takeover Speculation Moncler Reportedly Eyes Bid Melco Resorts MLCO Edges Lower Hovering Near Critical Support at 522 Robinhood Ventures Fund I RVI Tumbles 834 Key Support Levels in Focus Datadog DDOG Gains 196 as Shares Approach Key Resistance Level HCICU Holds Steady at 1004 A SPAC Unit Showing Stability Amid Market Uncertainty Momentus Inc MNTS Surges Over 70 Analyzing the Sharp Rally and Key Levels Intellia Therapeutics NTLA Rebounds GeneEditing Stock Shows Promise Near Support